Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesco Chiodo

Showing results (91-100 of 101) with videos related to

Pageof 11
Sort By:
AIDS Patient Care and Stds|September 11, 2009
Efficacy and safety of atazanavir-ritonavir plus abacavir-lamivudine or tenofovir-emtricitabine in patients with hyperlipidaemia switched from a stable protease inhibitor-based regimen including one thymidine analogueLeonardo Calza, Roberto Manfredi, Vincenzo Colangeli, et al.
Journal of Neurosurgery|May 13, 2004
Cerebral coenurosis. Case illustrationSergio Sabattani, Anna Federica Marliani, Federico Roncaroli, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|April 13, 2004
Ultrastructural liver mitochondrial abnormalities in HIV/HCV-coinfected patients receiving antiretroviral therapyGabriella Verucchi, Leonardo Calza, Carlo Biagetti, et al.
Journal of the American Academy of Dermatology|February 28, 2004
Disseminated cutaneous leishmaniasis after visceral disease in a patient with AIDSLeonardo Calza, Antonietta D'Antuono, Ginevra Marinacci, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|March 27, 2009
Plasma levels of VCAM-1, ICAM-1, E-Selectin, and P-Selectin in 99 HIV-positive patients versus 51 HIV-negative healthy controlsLeonardo Calza, Daria Pocaterra, Michele Pavoni, et al.
Journal of Medical Virology|August 21, 2007
RANKL/OPG/TRAIL plasma levels and bone mass loss evaluation in antiretroviral naive HIV-1-positive menDavide Gibellini, Marco Borderi, Elisa De Crignis, et al.
The Journal of Infection|February 16, 2008
HIV-1 DNA load analysis in peripheral blood lymphocytes and monocytes from naïve and HAART-treated individualsDavide Gibellini, Marco Borderi, Elisa De Crignis, et al.
The New Microbiologica|July 8, 2009
Prevalence of antiretroviral drug resistance in untreated persons newly diagnosed with HIV-1 infectionCarlo Biagetti, Isabella Bon, Francesca Vitone, et al.
AIDS (London, England)|April 13, 2004
Risk of failure in patients with 215 HIV-1 revertants starting their first thymidine analog-containing highly active antiretroviral therapyMichela Violin, Alessandro Cozzi-Lepri, Rossella Velleca, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 30, 2003
AIDS-related Kaposi's Sarcoma: evaluation of potential new prognostic factors and assessment of the AIDS Clinical Trial Group Staging System in the Haart Era--the Italian Cooperative Group on AIDS and Tumors and the Italian Cohort of Patients Naive From AntiretroviralsGuglielmo Nasti, Renato Talamini, Andrea Antinori, et al.
Pageof 11

Showing results (91-100 of 101) with videos related to

Sort By:
Pageof 11
AIDS Patient Care and Stds|September 11, 2009
Efficacy and safety of atazanavir-ritonavir plus abacavir-lamivudine or tenofovir-emtricitabine in patients with hyperlipidaemia switched from a stable protease inhibitor-based regimen including one thymidine analogueLeonardo Calza, Roberto Manfredi, Vincenzo Colangeli, et al.
Journal of Neurosurgery|May 13, 2004
Cerebral coenurosis. Case illustrationSergio Sabattani, Anna Federica Marliani, Federico Roncaroli, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|April 13, 2004
Ultrastructural liver mitochondrial abnormalities in HIV/HCV-coinfected patients receiving antiretroviral therapyGabriella Verucchi, Leonardo Calza, Carlo Biagetti, et al.
Journal of the American Academy of Dermatology|February 28, 2004
Disseminated cutaneous leishmaniasis after visceral disease in a patient with AIDSLeonardo Calza, Antonietta D'Antuono, Ginevra Marinacci, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|March 27, 2009
Plasma levels of VCAM-1, ICAM-1, E-Selectin, and P-Selectin in 99 HIV-positive patients versus 51 HIV-negative healthy controlsLeonardo Calza, Daria Pocaterra, Michele Pavoni, et al.
Journal of Medical Virology|August 21, 2007
RANKL/OPG/TRAIL plasma levels and bone mass loss evaluation in antiretroviral naive HIV-1-positive menDavide Gibellini, Marco Borderi, Elisa De Crignis, et al.
The Journal of Infection|February 16, 2008
HIV-1 DNA load analysis in peripheral blood lymphocytes and monocytes from naïve and HAART-treated individualsDavide Gibellini, Marco Borderi, Elisa De Crignis, et al.
The New Microbiologica|July 8, 2009
Prevalence of antiretroviral drug resistance in untreated persons newly diagnosed with HIV-1 infectionCarlo Biagetti, Isabella Bon, Francesca Vitone, et al.
AIDS (London, England)|April 13, 2004
Risk of failure in patients with 215 HIV-1 revertants starting their first thymidine analog-containing highly active antiretroviral therapyMichela Violin, Alessandro Cozzi-Lepri, Rossella Velleca, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 30, 2003
AIDS-related Kaposi's Sarcoma: evaluation of potential new prognostic factors and assessment of the AIDS Clinical Trial Group Staging System in the Haart Era--the Italian Cooperative Group on AIDS and Tumors and the Italian Cohort of Patients Naive From AntiretroviralsGuglielmo Nasti, Renato Talamini, Andrea Antinori, et al.
Pageof 11